Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B, Hou P.
BMC Cancer. 2012 Feb 1;12:50.
Related citations
Biomarkers for antitumor activity of bevacizumab in gastric cancer models.
Yamashita-Kashima Y, Fujimoto-Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, Mori K.
BMC Cancer. 2012 Jan 25;12:37. doi: 10.1186/1471-2407-12-37.
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.
Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA.
BMC Cancer. 2012 Jan 12;12:11.
Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F.
BMC Cancer. 2012 Jan 6;12:8.
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Cho SH, Chung IJ.
BMC Cancer. 2011 Nov 21;11:489.
TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child: evidence for chimerism involving a common mutant founder haplotype: case report.
da Silva EM, W Achatz MI, Martel-Planche G, Montagnini AL, Olivier M, Prolla PA, Hainaut P, Soares FA.
BMC Cancer. 2011 Oct 17;11:449. doi: 10.1186/1471-2407-11-449.
Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.
Zhou WH, Tang F, Xu J, Wu X, Feng ZY, Li HG, Lin DJ, Shao CK, Liu Q.
BMC Cancer. 2011 Sep 20;11:397.
Clinical management of gastric cancer: results of a multicentre survey.
Zhang X, Li N, Wei W, Yao W, Xie K, Hu J, Shen L, Ji W, Lu Y, Wen F, Jiang Y, Xu F, Feng H, Bi F, Li Q; Western Cooperative Gastrointestinal Oncology Group of China.
BMC Cancer. 2011 Aug 24;11:369.
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).
Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M, Cats A.
BMC Cancer. 2011 Aug 2;11:329.
Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.
Kim SY, Yoon J, Ko YS, Chang MS, Park JW, Lee HE, Kim MA, Kim JH, Kim WH, Lee BL.
BMC Cancer. 2011 Jun 22;11:264.
Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck.
Ma H, Wang LE, Liu Z, Sturgis EM, Wei Q.
BMC Cancer. 2011 Jun 20;11:258.
MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer.
Jian P, Yanfang T, Zhuan Z, Jian W, Xueming Z, Jian N.
BMC Cancer. 2011 May 26;11:200.
β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis.
Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J, Qu X, Liu Y.
BMC Cancer. 2011 May 20;11:183.
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
Gao J, Lu M, Yu JW, Li YY, Shen L.
BMC Cancer. 2011 May 18;11:177.
Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan.
Yang MD, Wang HC, Chang WS, Tsai CW, Bau DT.
BMC Cancer. 2011 May 17;11:174.
The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada.
Bashash M, Hislop TG, Shah AM, Le N, Brooks-Wilson A, Bajdik CD.
BMC Cancer. 2011 May 9;11:164.
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M.
BMC Cancer. 2011 Apr 6;11:122.
Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.
Li Y, Basang Z, Ding H, Lu Z, Ning T, Wei H, Cai H, Ke Y.
BMC Cancer. 2011 Apr 6;11:121.
P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.
Wei M, Wang Z, Yao H, Yang Z, Zhang Q, Liu B, Yu Y, Su L, Zhu Z, Gu Q.
BMC Cancer. 2011 Mar 27;11:109.
Prognostic impact of CD168 expression in gastric cancer.
Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki K, Kijima Y, Kitazono M, Natsugoe S.
BMC Cancer. 2011 Mar 24;11:106.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on